Air travel and incidence of pneumothorax in lymphangioleiomyomatosis.

TitreAir travel and incidence of pneumothorax in lymphangioleiomyomatosis.
Publication TypeJournal Article
Year of Publication2018
AuthorsGonano, C, Pasquier, J, Daccord, C, Johnson, SR, Harari, S, Leclerc, V, Falconer, L, Miano, E, Cordier, J-F, Cottin, V, Lazor, R
JournalOrphanet journal of rare diseases
Volume13
Issue1
Pagination222
Date Published12/2018
DOI10.1186/s13023-018-0964-6
ISSN1750-1172
Mots-clésAdult, Aged, Air travel, Air Travel/statistics & numerical data, Female, Humans, Incidence, Lymphangioleiomyomatosis, Lymphangioleiomyomatosis/epidemiology, Male, Middle Aged, Pleurodesis, Pneumothorax, Pneumothorax/epidemiology, Retrospective Studies
Abstract

BACKGROUND: Pulmonary lymphangioleiomyomatosis (LAM) is a rare disease of women characterized by multiple lung cysts leading to respiratory insufficiency and frequent pneumothorax (PT). Air travel (AT) could increase the risk of PT in LAM through rupture of subpleural cysts induced by atmospheric pressure changes in aircraft cabin. To determine whether AT increases the risk of PT in LAM, we performed a retrospective survey of members of European LAM patient associations. A flight-related PT was defined as occurring ≤30 days after AT.

RESULTS: 145 women reported 207 PT. In 128 patients with available data, the annual incidence of PT was 8% since the first symptoms of LAM and 5% since LAM diagnosis, compared to 0.006% in the general female population. Following surgical or chemical pleurodesis, the probability of remaining free of PT recurrence was respectively 82, 68, and 59% after 1, 5 and 10 years, as compared to only 55, 46 and 39% without pleurodesis (p = 0.026). 70 patients with available data performed 178 AT. 6 flight-related PT occurred in 5 patients. PT incidence since first symptoms of LAM was significantly higher ≤30 days after AT as compared to non-flight periods (22 versus 6%, risk ratio 3.58, confidence interval 1.40-7.45).

CONCLUSIONS: The incidence of PT in LAM is about 1000 times higher than in the general female population, and is further increased threefold after AT. Chemical or surgical pleurodesis partly reduces the risk of PT recurrence in LAM.

Alternate URL

http://www.ncbi.nlm.nih.gov/pubmed/30545392?dopt=Abstract

WOS ID (UT)

000453313400001

Alternate JournalOrphanet J Rare Dis
Citation Key / SERVAL ID9272
Peer reviewRefereed
PubMed ID30545392
PubMed Central IDPMC6293523

                         

IUMSP | www.iumsp.ch
Institut universitaire de médecine sociale et préventive
Route de la Corniche 10, 1010 Lausanne - Switzerland
+41 21 314 72 72 | iumsp@chuv.ch

Go to top